REQUEST A DEMO
Total
USD $0.00
Search more companies

Subira Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Subira Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Subira Pharmaceuticals Private Limited is a company based in India, with its head office in Mumbai. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on October 08, 2013. There was a net sales revenue increase of 32.2% reported in Subira Pharmaceuticals Private Limited’s latest financial highlights for 2024. Its’ total assets recorded a growth of 30.59%. In, 2024, the company’s net profit margin increased by 3.35%.

Legal Address
A-408, Fairlink Centre Chs Ltd. Off. Link Road, Andheri West
Mumbai; Maharashtra; Postal Code: 400053

Contact Details: Purchase the Subira Pharmaceuticals Private Limited report to view the information.

Website: http://www.subirapharma.in

Basic Information
Registered Capital:
Purchase the Subira Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Subira Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
October 08, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Subira Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
32.2%
Total Operating Revenue
31.92%
Operating Profit
90.61%
EBITDA
84.32%
Net Profit/Loss for the Period
92.2%
Total Assets
30.59%
Total Equity
33.51%
Operating Profit Margin
4.43%
Net Profit Margin
3.35%
Return on Equity (ROE)
7.66%
Debt / Equity
0%
Quick Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?